Posts by: Jose Marques Lopes, PhD

News

DxTerity Diagnostics’ LIFT study supports the use of social media to rapidly enroll lupus patients for clinical trials, as well as ensuring the accuracy of self-reported data and home-based ... Read more

June 8, 2018

Pediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

News

Early treatment to reduce disease activity and prevent irreversible organ damage in pediatric systemic lupus erythematosus (pSLE) patients should be strongly considered, according to new study. The research, “Pediatric ... Read more

May 23, 2018May 23, 2018

Cells that Fight Viruses May Trigger Immune Responses that Make Lupus Worse, Mouse Study Suggests

News

A type of immune cell that protects against viruses and cancer may worsen systemic lupus erythematosus (SLE) and trigger disease flares, a recent study with mice suggests. Led by ... Read more

May 9, 2018May 9, 2018

Lupus a Major Unrecognized Cause of Death in Young Women, Study Reports

News

Systemic lupus erythematosus (SLE) is a major cause of death in young women that goes largely unrecognized due to its exclusion from an annual nationwide ranking, a new U.S. study ... Read more

May 2, 2018May 2, 2018

Teens, Young Women with SLE Have Higher Risk of Adverse Pregnancy Outcomes, Study Shows

News

Teen and young women with systemic lupus erythematosus (SLE) have a higher risk of adverse pregnancy-related outcomes, including hypertensive disorders, maternal death, preterm birth, spontaneous abortion, and induced abortion, according ... Read more

April 4, 2018April 4, 2018

ImmuPharma Expects Top-Line Results of Lupuzor Phase 3 Trial by Mid-April

News

Top-line results of ImmuPharma’s Phase 3 clinical trial testing Lupuzor (rigerimod) as a systemic lupus erythematosus (SLE) treatment are expected by mid-April, according to the company. ImmuPharma also announced that database ... Read more

April 2, 2018April 2, 2018

Targeting Key Protein in Inflammation Could Prevent Lupus Kidney Damage, Study Suggests

News

Suppressing the key inflammatory protein iRhom2 reduced inflammation and prevented kidney scarring in mice susceptible to developing lupus, a study suggests. This approach could be the basis of new treatments ... Read more

March 28, 2018

New Way to Record a Key Nerve’s Signals Could Improve Lupus Treatment, Study Reports

News

New York scientists have come up with a new way to measure electric signals in the major nerve running from the head to the abdomen — a discovery that could ... Read more

March 9, 2018March 9, 2018

Many UK Lupus Patients Face Three-year Diagnosis Delay, Study Reports

News

It took more than three years for 1,000 Britons with lupus, scleroderma and vasculitis to obtain a correct diagnosis after their symptoms began, a study shows. The research was ... Read more

January 31, 2018January 31, 2018

Cancer Immunotherapy Does Not Increase Lupus Patients’ Risk of Autoimmune Reactions, Study Finds

News

Lupus patients’ risk of an autoimmune reaction while receiving a cancer immunotherapy is no greater than the general population’s, a Mayo Clinic study reports. The same is true of other rheumatic ... Read more

Posts by: Jose Marques Lopes, PhD

Jose Marques Lopes, PhD

DxTerity’s LIFT Study Supports Accuracy of Self-Reported Data in Lupus Patients

Pediatric Lupus Needs Early Treatment to Reduce Disease Activity, Prevent Organ Damage, Study Says

Cells that Fight Viruses May Trigger Immune Responses that Make Lupus Worse, Mouse Study Suggests

Lupus a Major Unrecognized Cause of Death in Young Women, Study Reports

Teens, Young Women with SLE Have Higher Risk of Adverse Pregnancy Outcomes, Study Shows

ImmuPharma Expects Top-Line Results of Lupuzor Phase 3 Trial by Mid-April

Targeting Key Protein in Inflammation Could Prevent Lupus Kidney Damage, Study Suggests

New Way to Record a Key Nerve’s Signals Could Improve Lupus Treatment, Study Reports

Many UK Lupus Patients Face Three-year Diagnosis Delay, Study Reports

Cancer Immunotherapy Does Not Increase Lupus Patients’ Risk of Autoimmune Reactions, Study Finds

Pin It on Pinterest